Requires registration and regulation of certain hemp-derived cannabinoids manufactured and sold in this State.
Introduced First Reading Assembly Referred to AOF
Summary
The bill would obligate manufacturers and retailers of hemp‑derived cannabinoids—such as Delta‑8‑THC foods, supplements, cosmetics and inhalables—to register with the state’s Cannabis Regulatory Commission, submit their products for safety testing, and provide accurate labeling. It targets companies that produce or sell these products in New Jersey to bring them under state oversight and protect consumers. The measure is intended to address the growing unregulated market for psychoactive hemp products.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when A 4082 changes status, plus AI-powered summaries and stage predictions.
Sign up free